Literature DB >> 4390412

Abnormal regulation of adenosine 3',5'-monophosphate and corticosterone formation in an adrenocortical carcinoma.

R L Ney, N J Hochella, D G Grahame-Smith, R N Dexter, R W Butcher.   

Abstract

A spontaneously occurring rat adrenocortical carcinoma which produces corticosterone was maintained by transplantation. The carcinoma appeared to utilize corticosterone biosynthetic steps similar to those of the normal adrenal, but the tumor produced only about 1-10% as much corticosterone per unit tissue weight as nontumorous adrenal glands. The tumor demonstrated little or no increase in corticosterone production in response to adrenocorticotropic hormone (ACTH) either in vivo or in vitro. In normal adrenals, ACTH increases the activity of adenyl cyclase which catalyzes the conversion of adenosine triphosphate (ATP) to adenosine-3',5'-monophosphate (cyclic AMP), the latter then serving as an intracellular regulator of steroidogenesis. ACTH failed to increase cyclic AMP levels in the tumor in vivo or in slices in vitro, conditions under which there were 50- and 20-fold increases in nontumorous adrenals. However, in homogenates fortified with exogenous ATP, adenyl cyclase activity was comparable in the tumor and adrenals, and cyclic AMP formation was increased 3-fold by ACTH in each. As measured in homogenates, the tumor did not possess a greater ability to destroy cyclic AMP than did normal adrenals. Although ATP levels in the carcinoma were found to be considerably lower than those in normal adrenals, it was not clear that this finding can explain the inability of ACTH to increase cyclic AMP levels in intact tumor cells. While the failure to normally influence cyclic AMP levels in the carcinoma cells could be an important factor in the lack of a steroid response to ACTH, several lines of evidence suggest that the tumor possesses one or more additional abnormalities in the regulation of steroidogenesis. First, in the absence of ACTH stimulation, the tissue concentrations of cyclic AMP were comparable in the tumor and in nontumorous adrenals, but these cyclic AMP levels were associated with a lower level of steroidogenesis in the tumor. Second, tumor slices failed to increase corticosterone production when incubated with cyclic AMP, in contrast to 5-fold increases observed with nontumorous adrenals.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4390412      PMCID: PMC535745          DOI: 10.1172/JCI106139

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  18 in total

1.  EFFECT OF ISCHEMIA ON KNOWN SUBSTRATES AND COFACTORS OF THE GLYCOLYTIC PATHWAY IN BRAIN.

Authors:  O H LOWRY; J V PASSONNEAU; F X HASSELBERGER; D W SCHULZ
Journal:  J Biol Chem       Date:  1964-01       Impact factor: 5.157

2.  The activation of adrenal phosphorylase by the adrenocorticotropic hormone.

Authors:  R C HAYNES
Journal:  J Biol Chem       Date:  1958-11       Impact factor: 5.157

3.  Variations in histologic pattern and functional effects of a transplantable adrenal cortical carcinoma in intact, hypophysectomized, and newborn rats.

Authors:  K C SNELL; H L STEWART
Journal:  J Natl Cancer Inst       Date:  1959-06       Impact factor: 13.506

4.  In vitro metabolism of progesterone-4-C-14 in an adrenocortical carcinoma of the rat.

Authors:  D F JOHNSON; K C SNELL; D FRANCOIS; E HEFTMANN
Journal:  Acta Endocrinol (Copenh)       Date:  1961-07

5.  Formation of a cyclic adenine ribonucleotide by tissue particles.

Authors:  T W RALL; E W SUTHERLAND
Journal:  J Biol Chem       Date:  1958-06       Impact factor: 5.157

6.  Practical procedure for estimation of corticosterone or hydrocortisone.

Authors:  R H SILBER; R D BUSCH; R OSLAPAS
Journal:  Clin Chem       Date:  1958-08       Impact factor: 8.327

7.  A revision of the Schoenheimer-Sperry method for cholesterol determination.

Authors:  W M SPERRY; M WEBB
Journal:  J Biol Chem       Date:  1950-11       Impact factor: 5.157

8.  A study of mechanisms by which adrenocorticotropic hormone maintains adrenal steroidogenic responsiveness.

Authors:  R L Ney; R N Dexter; W W Davis; L D Garren
Journal:  J Clin Invest       Date:  1967-12       Impact factor: 14.808

9.  Amino-glutethimide and metastatic adrenal cancer. Maintained reversal (six months) of Cushing's syndrome.

Authors:  D E Schteingart; R Cash; J W Conn
Journal:  JAMA       Date:  1966-11-28       Impact factor: 56.272

10.  Adenosine 3',5'-monophosphate in biological materials. II. The measurement of adenosine 3',5'-monophosphate in tissues and the role of the cyclic nucleotide in the lipolytic response of fat to epinephrine.

Authors:  R W Butcher; R J Ho; H C Meng; E W Sutherland
Journal:  J Biol Chem       Date:  1965-11       Impact factor: 5.157

View more
  13 in total

1.  Novel protein kinase, AUT-PK 85, isolated from adrenocortical carcinoma: purification and characterization.

Authors:  G Shanker; H Ahrens; R K Sharma
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

2.  ACTH and prostaglandin receptors in human adrenocortical tumors. Apparent modification of a specific component of the ACTH-binding site.

Authors:  J M Saez; A Dazord; D Gallet
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

3.  Study of the activity of head ganglion cells of larvae of the Drosophila ts-mutant with altered capacity for learning and increased activational properties of calmodulin.

Authors:  E V Tokmacheva
Journal:  Neurosci Behav Physiol       Date:  1996 Sep-Dec

4.  Ultrastructural study of two gonadotrophs in rats bearing an adrenocortical carcinoma (Snell 494).

Authors:  I Nakayama; P A Nickerson
Journal:  Am J Pathol       Date:  1973-05       Impact factor: 4.307

5.  Regulation of adrenal ornithine decarboxylase by adrenocorticotropic hormone and cyclic AMP.

Authors:  R Richman; C Dobbins; S Voina; L Underwood; D Mahaffee; J Van Wyk; R L Ney
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

6.  The functions of adenosine 3':5'-cyclic monophosphate.

Authors:  R Kilpatrick; P W Major
Journal:  Biochem J       Date:  1970-12       Impact factor: 3.857

7.  Abnormal hormone responses of an adrenocortical cancer adenyl cyclase.

Authors:  I Schorr; R L Ney
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

8.  The effects of ACTH on steroid metabolomic profiles in human adrenal cells.

Authors:  Yewei Xing; Michael A Edwards; Clarence Ahlem; Mike Kennedy; Anthony Cohen; Celso E Gomez-Sanchez; William E Rainey
Journal:  J Endocrinol       Date:  2011-03-23       Impact factor: 4.286

9.  Ectopic beta-adrenergic receptor binding sites. possible molecular basis of aberrant catecholamine responsiveness of an adrenocortical tumor adenylate cyclase.

Authors:  L T Williams; T B Gore; R J Lefkowitz
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

10.  An effect of dexamethasone on adenosine 3',5'-monophosphate content and adenosine 3',5'-monophosphate phosphodiesterase activity of cultured hepatoma cells.

Authors:  V Manganiello; M Vaughan
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.